《全日速報》恆指全日收報24,355點 跌200點; 恆生科技指數全日收報5,490點 跌11點 平安跌逾3% 成交暢旺
恆指全日收24,355點,跌200點或0.8%。恆生科技指數報5,490點,跌11點或0.2%。國指跌90點或1.0%,報8,528點。大市成交額1,141.39億元。
活躍重磅股表現:
平安(02318.HK) 收64.3元,下跌3.5%;
建行(00939.HK) 收5.96元,下跌2.9%;
美團(03690.HK) 收214元,下跌2.6%;
友邦(01299.HK) 收86.7元,下跌0.6%;
騰訊(00700.HK) 收470元,下跌0.4%;
阿裏巴巴(09988.HK) 收118.4元,下跌0.3%;
港交所(00388.HK) 收437.2元,下跌0%;
異動恆指及國指成份股:
信達生物(01801.HK) 收33.45元,上升16.8%;
藥明生物(02269.HK) 收61.65元,上升10.1%;
郵儲銀行(01658.HK) 收6.33元,下跌4.5%;
信義光能(00968.HK) 收14.12元,上升4.4%;
中銀香港(02388.HK) 收30.5元,下跌4.1%;
華潤啤酒(00291.HK) 收62.6元,上升3.7%;
中石化(00386.HK) 收4.03元,下跌3.6%;
中石油(00857.HK) 收4.1元,下跌3.5%;
國壽(02628.HK) 收13.98元,下跌3.5%;
京東物流(02618.HK) 收24.5元,上升3.2%;
異動綜合中小型股:
四環醫藥(00460.HK) 收1.91元,上升19.4%;
正榮地產(06158.HK) 收0.88元,下跌15.4%;
金斯瑞生物科技(01548.HK) 收27.85元,上升12.8%;
藥明康德(02359.HK) 收101.7元,上升12.1%;
康方生物(09926.HK) 收20.7元,上升10.7%;
時代天使(06699.HK) 收177.1元,上升10.4%;
祥生控股集團(02599.HK) 收0.95元,下跌10.4%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.